poisar

Stocks · News reference

JonesTrading Maintains Buy Rating and $82 Price Target for Rapport Therapeutics

Fiscal.ai

JonesTrading analyst Justin Walsh has reaffirmed a 'Buy' rating and a $82 price target for Rapport Therapeutics, Inc. (NASDAQ: RAPP).

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading